Sepse: Critical Analysis of New Sepse Definitions and Retrospective Evaluation of Sepse Protocol at a Tertiary Hospital in Brazil

Sepse: Critical Analysis of New Sepse Studies and Definitions and Retrospective Evaluation of Sepse Protocol Implementation at Hospital Unimed Volta Redonda

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03217981

Acronym

HUVR

Enrollment

506

Registered

2017-07-14

Start date

2017-08-02

Completion date

2017-08-08

Last updated

2017-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Brief summary

Research in the databases Lilacs, BIREME, SciELO by the terms: systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis and septic shock and their equivalents in the English language. Selection of the main articles of the last five years to study and contextualize the reality presented since the implantation of the HUVR sepsis protocol. Statistical analysis of data since the implementation of the sepsis protocol in the HUVR, in July 2014 until June 2016.

Interventions

OTHERSepsis protocol

Adherence to the sepsis protocol

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

All individuals who had a confirmed or suspected sepsis diagnosis and had a sepsis protocol completed during the study period. \-

Exclusion criteria

Individuals with confirmed or suspected sepsis in the study period who did not complete the protocol. Individuals under the age of 18 \-

Design outcomes

Primary

Measure	Time frame	Description
Adherence to the sepsis protocol	From 2014 to 2016	Implementation of the measures recommended in the sepsis protocol

Secondary

Measure	Time frame	Description
Sepsis mortality rate	From 2014 to 2016	Assessment of the evolution of the sepsis mortality rate

Countries

Brazil

Contacts

Primary ContactVicente L da Silva Jr

vicente.junior@unimedvr.com.br+5521981227376

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026